Quantitative analysis method for simultaneously and rapidly detecting residual quantity of ethylene oxide, 2-chloroethanol and ethylene glycol in medical instrument product

Through gas chromatography-hydrogen flame ion detector and purified water extraction method, rapid detection of ethylene oxide, 2-chloroethanol and ethylene glycol residues in medical device products is achieved, and the detection efficiency in the prior art is solved The low problem has improved product safety evaluation.

CN118961959APending Publication Date: 2024-11-15SICHUAN PROVINCIAL INST FOR DRUG CONTROL (SICHUAN MEDICAL DEVICE TESTING CENT)

Patent Information

Application Number
CN202411030673.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-30
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The prior art cannot simultaneously detect the residual amount of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products, resulting in insufficiency of detection.

Method used

Using gas chromatography-hydrogen flame ion detector combined with purified water extraction method, the residues in medical device products are quantitatively analyzed by standard curve fitting equations, and the simultaneous rapid detection of ethylene oxide, 2-chloroethanol and ethylene glycol are achieved. .

Benefits of technology

It improves the rapid detection efficiency of ethylene oxide, 2-chloroethanol and ethylene glycol residues in medical device products, and enhances the evaluation of product safety.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118961959A_ABST
    Figure CN118961959A_ABST
Patent Text Reader

Abstract

The invention discloses a quantitative analysis method for simultaneously and rapidly detecting residual quantity of ethylene oxide, 2-chloroethanol and ethylene glycol in a medical instrument product, which comprises the following steps of: releasing sterilization residues in a medical instrument product sample by leaching with purified water; and introducing the extracted sterilization residue liquid into a gas chromatography-hydrogen flame ionization detector, analyzing, and inputting the chromatographic peak area obtained by the gas chromatography-hydrogen flame ionization detector into the corresponding calibration curve fitting equation of the sterilization residue to obtain the corresponding target compound concentration. And the contents of the corresponding three sterilization residues in the medical instrument product are obtained through conversion. The method is based on purified water extraction, adopts a liquid sample injection mode, and performs rapid quantitative analysis on three sterilized residues in a medical instrument product at the same time through specific chromatographic conditions and detector conditions, and the detection efficiency is high.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of analytical chemical detection technology, and specifically to a quantitative analysis method for simultaneously and rapidly detecting the residual amounts of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products. Background Art

[0002] Ethylene oxide sterilization is the most commonly used method for sterilization control of medical devices before use. Ethylene oxide has been recognized worldwide as a gas sterilization method. With the development of industrialization, it is widely used to sterilize medical devices that are not resistant to high temperature, high pressure and high humidity. However, ethylene oxide sterilization also has certain disadvantages. In particular, the residues after sterilization are a major threat to related users or operators, causing serious damage to mucosal tissues and causing cell aberrations and cancer. Common residues include ethylene oxide, 2-chloroethanol, and ethylene glycol.

[0003] After ethylene oxide (EO) sterilizes medical devices, it is necessary to ensure that the residual levels of EO, 2-chloroethanol (ECH) and ethylene glycol (EG) pose minimal risk to patients during normal use of the product. Currently available methods or standards can only detect EO, ECH or EG one by one, and there is no method to detect the three substances at the same time, resulting in low detection efficiency. Summary of the invention

[0004] The object of the present invention is to provide a quantitative analysis method for simultaneously and rapidly detecting the residual amounts of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products, and proposes a gas chromatography method for simultaneously determining ethylene oxide sterilization residues, namely ethylene oxide, 2-chloroethanol and ethylene glycol, to solve the above-mentioned technical problems existing in the prior art.

[0005] In order to solve the above technical problems, the present invention adopts the following solutions:

[0006] A quantitative analysis method for simultaneously and rapidly detecting the residual amounts of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products, wherein sterilization residues in a medical device product sample are released by extraction with purified water, the extracted sterilization residue liquid is sampled into a gas chromatography-hydrogen flame ionization detector and analyzed, the chromatographic peak area obtained by the gas chromatography-hydrogen flame ionization detector is input into a corresponding calibration curve fitting equation of the sterilization residue, the corresponding target compound concentration is obtained, and the corresponding contents of the three sterilization residues in the medical device product are obtained by conversion.

[0007] Preferably, the steps include:

[0008] Step 1: Sample pretreatment: release the sterilization residue in the medical device product sample by leaching with purified water, and directly inject the sterilization residue liquid after leaching into the gas chromatography-hydrogen flame ionization detector;

[0009] Step 2: Determine the instrument analysis conditions: including chromatographic conditions and detector conditions;

[0010] Step three, standard curve quantification: obtain the standard curve fitting equation and linear correlation coefficient of the three sterilization residues; perform gas chromatography-hydrogen flame ion analysis on the sterilization residue liquid after extraction in step one according to the conditions of step two, obtain the chromatographic peak areas of the three substances in the actual medical device product sample, input the corresponding standard curve fitting equation, obtain the corresponding target compound concentration, and obtain the corresponding content of the three sterilization residues in the medical device product by conversion.

[0011] Preferably, the sterilization residues are ethylene oxide, 2-chloroethanol and ethylene glycol.

[0012] Preferably, step one comprises: placing the shredded medical device product sample in a gas phase bottle, adding purified water into the gas phase bottle, and extracting for 2 hours to 24 hours to obtain a sterilization residue extract; placing the sterilization residue extract in a sample injection bottle for gas chromatography detection.

[0013] Preferably, the injection method is liquid injection.

[0014] Preferably, 1 g of the shredded medical device product sample is weighed.

[0015] Preferably, the extraction temperature is 37°C.

[0016] Preferably, in the step 2:

[0017] Chromatographic conditions: chromatographic column, DB-wax, 30m×530μm×1.0μm; injection volume, 1μL; split ratio, splitless; injection port temperature, 250℃; temperature program conditions, start at 40℃, hold for 0.5min, increase the temperature to 135℃ at 40℃ / min, hold for 7min, then increase the temperature to 230℃ at 40℃ / min, hold for 3min;

[0018] Detector conditions: hydrogen flame ionization detector, hydrogen flow rate, 40 mL / min; air flow rate, 400 mL / min; tail gas nitrogen flow rate, 10 mL / min; data acquisition frequency, 20 Hz.

[0019] Preferably, the step three comprises:

[0020] S31, preparation of standard mixed solution: measure or weigh 0.25mL of 10mg / mL ethylene oxide, 25mg of 2-chloroethanol and 25mg of ethylene glycol respectively and place them in different 25mL volumetric flasks, dilute to volume with purified water, prepare single standard stock solutions, and store at 4°C; take 1mL of each single standard stock solution to the same 10mL volumetric flask, dilute to volume with purified water, and prepare mixed standard solutions of 10μg / mL ethylene oxide, 100μg / mL 2-chloroethanol and 100μg / mL ethylene glycol; take this mixed standard solution as the upper limit of the standard curve concentration, dilute the mixed standard solution step by step for 6 times, and prepare 7 standard mixed solutions with different concentrations;

[0021] The standard mixed solution:

[0022] The concentrations of ethylene oxide were 0.5 g / mL, 1.0 g / mL, 2.0 g / mL, 4.0 g / mL, 5.0 g / mL, 6.0 g / mL, and 10 g / mL;

[0023] The concentrations of 2-chloroethanol were 5 μg / mL, 10 μg / mL, 20 μg / mL, 40 μg / mL, 50 μg / mL, 60 μg / mL, and 100 μg / mL;

[0024] The concentrations of ethylene glycol were 5 μg / mL, 10 μg / mL, 20 μg / mL, 40 μg / mL, 50 μg / mL, 60 μg / mL, and 100 μg / mL;

[0025] S32, analyzing the prepared mixed standard solutions of different concentrations using a gas chromatography-hydrogen flame ionization detector according to the chromatographic conditions and detector conditions set in step 2, obtaining the chromatographic mass spectrometry peak area corresponding to each concentration gradient mixed standard solution, and performing linear fitting on the obtained peak area and the corresponding concentration gradient to obtain a calibration curve fitting equation and a linear correlation coefficient;

[0026] S33, the sterilization residue extract in step one is analyzed by chromatographic gas spectrometry-hydrogen flame ionization detector according to the chromatographic conditions and detector conditions set in step two, and the chromatogram areas of ethylene oxide, 2-chloroethanol and ethylene glycol contained in the actual medical device product are obtained, and the calibration curve fitting equation is input to calculate the corresponding substance concentration in ug / mL.

[0027] Preferably, the calibration curve fitting equation is: X=c / 5;

[0028] Among them, X represents the content of three sterilization residues in the sample, in μg / g; c represents the concentration of the measured component obtained from the standard curve, in μg / mL.

[0029] The beneficial effects of the present invention are as follows: the present invention is a quantitative analysis method for simultaneously and rapidly detecting the residual amounts of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products. The medical device products are cut into pieces and then directly extracted with purified water to obtain a sterilization residue extract. The liquid sampling method and the optimization of the gas chromatography-hydrogen flame ionization detector conditions are adopted to achieve rapid detection and quantification of three residual substances, ethylene oxide, 2-chloroethanol and ethylene glycol, in the medical device products, thereby improving the detection efficiency and evaluating the safety of the medical device products. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 This is a gas chromatography-flame ionization detector separation chromatogram of three sterilization residues of ethylene oxide, 2-chloroethanol and ethylene glycol using headspace gas injection in Example 1 of the present invention.

[0031] Figure 2 This is a gas chromatography-flame ionization detector separation chromatogram of three sterilization residues of ethylene oxide, 2-chloroethanol and ethylene glycol using liquid injection in Example 1 of the present invention, wherein the chromatographic column is DB-wax without splitting.

[0032] Figure 3 This is a gas chromatography-flame ionization detector separation chromatogram of three sterilization residues of ethylene oxide, 2-chloroethanol and ethylene glycol using chromatographic column DB-624 in Example 1 of the present invention.

[0033] Figure 4 This is a gas chromatography-flame ionization detector separation chromatogram of three sterilization residues of ethylene oxide, 2-chloroethanol and ethylene glycol using a chromatographic column HP-5 in Example 1 of the present invention.

[0034] Figure 5 This is a gas chromatography-flame ionization detector separation chromatogram of three sterilization residues of ethylene oxide, 2-chloroethanol and ethylene glycol with a split ratio of 5:1 in Example 1 of the present invention, and a temperature program condition 3 is used at the same time.

[0035] Figure 6 This is a gas chromatography-flame ionization detector separation chromatogram of three sterilization residues of ethylene oxide, 2-chloroethanol and ethylene glycol using temperature program condition 1 in Example 1 of the present invention.

[0036] Figure 7 This is a gas chromatography-flame ionization detector separation chromatogram of three sterilization residues of ethylene oxide, 2-chloroethanol and ethylene glycol using temperature program condition 2 in Example 1 of the present invention.

[0037] Wherein: EO is ethylene oxide, ECH is 2-chloroethanol, and EG is ethylene glycol. DETAILED DESCRIPTION

[0038] In order to make the purpose, technical solution and advantages of the embodiment of the present invention clearer, the technical solution of the embodiment of the present invention will be clearly and completely described below in conjunction with the drawings of the embodiment of the present invention. Obviously, the described embodiment is a part of the embodiment of the present invention, not all of the embodiments. Based on the described embodiment of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0039] The instruments and reagents used in Examples 1 to 3 of the present invention are: gas chromatography-flame ionization detector (Agilent Technologies Inc.) and Millipore ultrapure water machine (Millipore Technologies Inc., USA).

[0040] Experimental reagents: PVC infusion set; ethylene oxide standard, 11 mg / mL, purchased from China Food and Drug Inspection Institutes; 2-chloroethanol, purity ≥99%, produced by Xinyang Zhongjian Metrology Biotechnology Co., Ltd.; ethylene glycol, 100 mg, purity 100%, purchased from China Food and Drug Inspection Institutes; experimental water was purified water.

[0041] Example 1

[0042] This example is the screening of the injection method, chromatographic column, split ratio, and temperature program of ethylene oxide, 2-chloroethanol, and ethylene glycol.

[0043] (1) Screening of injection methods

[0044] Table 1 Effects of different injection methods on the chromatographic signals of ethylene oxide, 2-chloroethanol and ethylene glycol

[0045] Injection method Ethylene oxide (EO) 2-Chloroethanol(ECH) Ethylene glycol (EG) Headspace gas injection Strong chromatographic signal Weak chromatographic signal No chromatographic signal was observed Liquid injection Strong chromatographic signal Strong chromatographic signal Strong chromatographic signal

[0046] Two sampling methods were used to collect and sample the test solution, and the data signal was collected through the FID detector. As shown in Table 1: No EG chromatographic signal was observed in the headspace gas sampling method (refer to Figure 1 ), and the chromatographic signal of ECH is weak. In the liquid injection method, the chromatographic signals of EG and ECH are both strong (refer to Figure 2 ).

[0047] (2) Screening of chromatographic columns

[0048] Table 2 Effects of different chromatographic columns on the chromatographic signals of ethylene oxide, 2-chloroethanol and ethylene glycol

[0049]

[0050] As shown in Table 2, the chromatographic signal intensity of the DB-wax chromatographic column is high, the symmetry is better, and there is no obvious tailing phenomenon. Therefore, DB-wax is selected as the chromatographic column of the present invention. Figure 2 , Figure 3 and Figure 4 .

[0051] (3) Split ratio screening

[0052] The split ratio of 5:1 and no split conditions were tested respectively, referring to Figure 1 and Figure 5 ,The results show that the signal strength increases as the split ratio decreases, so no splitting is chosen to obtain the highest signal strength.

[0053] (4) Screening of heating program conditions

[0054] Since ethylene oxide (EO) has a low boiling point, 40°C was selected as the starting temperature for subsequent gradient temperature increase.

[0055] Heating program condition 1: heating to 230°C at 40°C / min and maintaining for 3 min;

[0056] Temperature program condition 2: increase the temperature to 135°C at 40°C / min, hold for 3 min, then increase the temperature to 230°C at 40°C / min, hold for 3 min;

[0057] Temperature program condition 3: heat to 135°C at 40°C / min, hold for 7 min, then heat to 230°C at 40°C / min, hold for 3 min.

[0058] Reference Figure 5-Figure 7 , where in temperature program condition 3: dimethyl sulfoxide and ethylene glycol (EG) in ethylene oxide (EO) standard substance have good separation, so temperature program condition 3 is selected.

[0059] Example 2

[0060] This embodiment 2 is based on the conditions after screening in embodiment 1, and is a quantitative analysis method for simultaneously and rapidly detecting the residual amounts of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products, comprising the following steps:

[0061] Step 1, sample pretreatment: extract the sterilization residue contained in the ethylene oxide sterilization residue sample to be analyzed. Take the sterilized PVC infusion set sample, cut it into pieces, accurately weigh 1g of the sample and put it into a 20mL gas phase bottle, add 10mL of purified water solution, and extract at 37℃ for 2h, 18h, and 24h to obtain the sterilization residue extract. Transfer the sterilization residue extract into a 1mL injection vial and analyze it on a gas chromatograph.

[0062] Step 2: Determine the instrument analysis conditions:

[0063] Chromatographic conditions: chromatographic column, DB-wax, 30m×530μm×1.0μm; injection volume, 1μL; split ratio, splitless; injection port temperature, 250℃; temperature program conditions, start at 40℃, hold for 0.5min, increase the temperature to 135℃ at 40℃ / min, hold for 7min, then increase the temperature to 230℃ at 40℃ / min, hold for 3min;

[0064] Detector conditions: hydrogen flame ionization detector, hydrogen flow rate, 40 mL / min; air flow rate, 400 mL / min; tail gas nitrogen flow rate, 10 mL / min; data acquisition frequency, 20 Hz.

[0065] When selecting the injection volume, 1μL and 2μL injection volumes were tested, and the results showed that the higher the injection volume, the stronger the detection signal intensity. However, since the liquid is directly injected, all the impurities in the sample will enter the chromatographic column. If the injection volume is higher, the impurities in the sample will cause greater damage to the chromatographic column. When the injection volume is 1μL, combined with other experimental conditions, it has a higher signal intensity, so the injection volume is selected as 1μL.

[0066] Step 3: Standard curve quantification:

[0067] S31, preparation of standard mixed solution: measure or weigh 0.25mL of 10mg / mL ethylene oxide, 25mg of 2-chloroethanol (purity 99%) and 25mg of ethylene glycol respectively and place them in different 25mL volumetric flasks, make up to volume with purified water, prepare single standard stock solutions, and store them at 4°C; take 1mL of each single standard stock solution to the same 10mL volumetric flask, make up to volume with purified water, and prepare mixed standard solutions of 10μg / mL ethylene oxide, 100μg / mL 2-chloroethanol and 100μg / mL ethylene glycol; use this mixed standard solution as the upper limit of the standard curve concentration, dilute the mixed standard solution step by step for 6 times, and prepare 7 standard mixed solutions with different concentrations.

[0068] The standard mixed solution:

[0069] The concentrations of ethylene oxide were 0.5 g / mL, 1.0 g / mL, 2.0 g / mL, 4.0 g / mL, 5.0 g / mL, 6.0 g / mL, and 10 g / mL;

[0070] The concentrations of 2-chloroethanol were 5 μg / mL, 10 μg / mL, 20 μg / mL, 40 μg / mL, 50 μg / mL, 60 μg / mL, and 100 μg / mL;

[0071] The concentrations of ethylene glycol were 5 μg / mL, 10 μg / mL, 20 μg / mL, 40 μg / mL, 50 μg / mL, 60 μg / mL, and 100 μg / mL;

[0072] The prepared standard mixed solutions of different concentrations were analyzed by gas chromatography-hydrogen flame ionization detector according to the chromatographic conditions and detector conditions set in step 2 to obtain the chromatographic mass spectrometry peak area corresponding to each concentration gradient standard mixed solution, and the obtained peak area and its corresponding concentration gradient were linearly fitted to obtain the calibration curve fitting equation and linear correlation coefficient, as shown in Table 3.

[0073] Table 3 Quantitative calibration curves and detection limits and quantification limits of three residues in medical device products

[0074]

[0075] The sterilization residue extract in step 1 is analyzed by chromatographic gas spectrometry-hydrogen flame ionization detector according to the conditions of step 2 to obtain the chromatogram area of ​​ethylene oxide, 2-chloroethanol and ethylene glycol contained in the actual medical device product, and the calibration curve fitting equation is input to calculate the corresponding substance concentration in μg / mL. The content of the three residues in the medical device product (here, the PVC infusion set) is calculated according to the formula X=c / 5.

[0076] Where: X represents the content of three sterilization residues in the sample, in μg / g; c represents the concentration of the measured component obtained from the standard curve, in μg / mL.

[0077] Example 3

[0078] This Example 3 is a quantitative analysis method for simultaneously and rapidly detecting the residual amounts of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products. The experimental steps are the same as those in Example 2.

[0079] The contents of the three types of residues in the medical device product (here, the PVC infusion set) are calculated according to the formula X=c / 5 as shown in Table 4.

[0080] Table 4 Distribution of three residues in medical device products

[0081]

[0082] It can be seen from Table 4 that the contents of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products can be detected under the condition of 2h extraction, and the contents increase with the increase of extraction time, indicating that this method can achieve rapid detection of the three residues.

[0083] The above description is only a preferred embodiment of the present invention and does not constitute any form of limitation to the present invention. Although the present invention has been disclosed as a preferred embodiment as above, it is not intended to limit the present invention. Any technician familiar with the profession can make some changes or modifications to equivalent embodiments of equivalent changes using the technical contents disclosed above without departing from the scope of the technical solution of the present invention. However, any simple modification, equivalent changes and modifications made to the above embodiments based on the technical essence of the present invention without departing from the content of the technical solution of the present invention still fall within the scope of the technical solution of the present invention.

Claims

1. A quantitative analysis method for simultaneously and rapidly detecting the residual amounts of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products, characterized in that: The sterilization residues in the medical device product samples are released by purified water extraction, the extracted sterilization residue liquid is injected into the gas chromatography-hydrogen flame ionization detector and analyzed, the chromatographic peak area obtained by the gas chromatography-hydrogen flame ionization detector is input into the corresponding calibration curve fitting equation of the sterilization residue to obtain the corresponding target compound concentration, and the corresponding contents of the three sterilization residues in the medical device products are obtained by conversion.

2. A quantitative analysis method for simultaneously and rapidly detecting the residual amounts of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products according to claim 1, characterized in that: The following steps are involved: Step 1: Sample pretreatment: release the sterilization residue in the medical device product sample by leaching with purified water, and directly inject the sterilization residue liquid after leaching into the gas chromatography-hydrogen flame ionization detector; Step 2: Determine the instrument analysis conditions: including chromatographic conditions and detector conditions; Step three, standard curve quantification: obtain the standard curve fitting equation and linear correlation coefficient of the three sterilization residues; perform gas chromatography-hydrogen flame ion analysis on the sterilization residue liquid after extraction in step one according to the conditions of step two, obtain the chromatographic peak areas of the three substances in the actual medical device product sample, input the corresponding standard curve fitting equation, obtain the corresponding target compound concentration, and obtain the corresponding content of the three sterilization residues in the medical device product by conversion.

3. A quantitative analysis method for simultaneously and rapidly detecting the residual amounts of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products according to claim 2, characterized in that: The sterilization residues are ethylene oxide, 2-chloroethanol and ethylene glycol.

4. A quantitative analysis method for simultaneously and rapidly detecting the residual amounts of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products according to claim 2, characterized in that: The step one comprises: placing the shredded medical device product sample in a gas phase bottle, adding purified water into the gas phase bottle, and extracting for 2 hours to 24 hours to obtain a sterilization residue extract; placing the sterilization residue extract in a sample injection bottle for gas chromatography detection.

5. A quantitative analysis method for simultaneously and rapidly detecting the residual amounts of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products according to claim 4, characterized in that: The injection method is liquid injection.

6. A quantitative analysis method for simultaneously and rapidly detecting the residual amounts of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products according to claim 4, characterized in that: Weigh 1 g of the shredded medical device product sample.

7. A quantitative analysis method for simultaneously and rapidly detecting the residual amounts of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products according to claim 4, characterized in that: The extraction temperature was 37°C.

8. A quantitative analysis method for simultaneously and rapidly detecting the residual amounts of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products according to claim 4, characterized in that: In the step 2: Chromatographic conditions: chromatographic column, DB-wax, 30m×530μm×1.0μm; injection volume, 1μL; split ratio, splitless; injection port temperature, 250℃; temperature program conditions, start at 40℃, hold for 0.5min, increase the temperature to 135℃ at 40℃ / min, hold for 7min, then increase the temperature to 230℃ at 40℃ / min, hold for 3min; Detector conditions: hydrogen flame ionization detector, hydrogen flow rate, 40 mL / min; Air flow rate, 400mL / min; tail gas nitrogen flow rate, 10mL / min; Data acquisition frequency, 20 Hz.

9. A quantitative analysis method for simultaneously and rapidly detecting the residual amounts of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products according to claim 4, characterized in that: The step three comprises: S31, preparation of standard mixed solution: measure or weigh 0.25mL of 10mg / mL ethylene oxide standard solution, 25mg of 2-chloroethanol and 25mg of ethylene glycol respectively, place them in different 25mL volumetric flasks, dilute to volume with purified water, prepare single standard stock solutions, and store them at 4°C; take 1ml of each single standard stock solution to the same 10mL volumetric flask, dilute to volume with purified water, prepare mixed standard solutions of 10μg / mL ethylene oxide, 100μg / mL 2-chloroethanol and 100μg / mL ethylene glycol; take this mixed standard solution as the upper limit of the standard curve concentration, dilute the mixed standard solution step by step for 6 times, and prepare 7 standard mixed solutions of different concentrations; The standard mixed solution: The concentrations of ethylene oxide were 0.5 g / mL, 1.0 g / mL, 2.0 g / mL, 4.0 g / mL, 5.0 g / mL, 6.0 g / mL, and 10 g / mL; The concentrations of 2-chloroethanol were 5 μg / mL, 10 μg / mL, 20 μg / mL, 40 μg / mL, 50 μg / mL, 60 μg / mL, and 100 μg / mL; The concentrations of ethylene glycol were 5 μg / mL, 10 μg / mL, 20 μg / mL, 40 μg / mL, 50 μg / mL, 60 μg / mL, and 100 μg / mL; S32, analyzing the prepared mixed standard solutions of different concentrations using a gas chromatography-hydrogen flame ionization detector according to the chromatographic conditions and detector conditions set in step 2, obtaining the chromatographic mass spectrometry peak area corresponding to each concentration gradient mixed standard solution, and performing linear fitting on the obtained peak area and the corresponding concentration gradient to obtain a calibration curve fitting equation and a linear correlation coefficient; S33, the sterilization residue extract in step one is analyzed by chromatographic gas spectrometry-hydrogen flame ionization detector according to the chromatographic conditions and detector conditions set in step two, and the chromatogram areas of ethylene oxide, 2-chloroethanol and ethylene glycol contained in the actual medical device product are obtained, and the calibration curve fitting equation is input to calculate the corresponding substance concentration in ug / mL.

10. A quantitative analysis method for simultaneously and rapidly detecting the residual amounts of ethylene oxide, 2-chloroethanol and ethylene glycol in medical device products according to claim 9, characterized in that: The calibration curve fitting equation is: X=c / 5; Among them, X represents the content of three sterilization residues in the sample, in μg / g; c represents the concentration of the measured component obtained from the standard curve, in μg / mL.

Citation Information

Patent Citations

  • Headspace gas chromatography-mass spectrometry determination method of 2-chloroethanol in water

    CN108426958A

  • Kit and method for rapidly detecting total amount of ethylene oxide and 2-chloroethanol in medical instrument

    CN111537501A

  • Method for detecting and analyzing residual amount of ethylene oxide in mask

    CN113624884A

Cited By

  • Integrated detection system and method for residual quantity of multiple types of cleaning agents after medical instrument cleaning

    CN121475747A